# Cage Pharmaceuticals, Inc. — Form D

Cage Pharmaceuticals, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-31. The offering totals $137K, of which $137K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2024-05-31
- Form: D
- Accession: 0001727073-24-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $137K
- Amount sold: $137K
- Investors: 2
- Date of first sale: 2024-05-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-514783

## Issuer

- Name: Cage Pharmaceuticals, Inc.
- CIK: 0001727073
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 512 W. 22nd Street, New York, NY, 10011
- Phone: 917-832-1832

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Brian Malik | Director | New York, NY |
| Peter Olagunju | Director | Houston, TX |
| Nick Papadopoulos | Director | New York, NY |
| Isaac Ro | Director | San Mateo, CA |
| Peter Olagunju | Executive Officer | Houston, TX |
| Jason Rifkin | Executive Officer | New York, NY |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-07-12](https://search.stillhousedata.com/formd/0001727073-19-000001) | D | $480K | $480K |
| [2018-01-05](https://search.stillhousedata.com/formd/0001727073-18-000001) | D | $1.7M | $350K |

## More

- [CIK 1727073 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1727073&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001727073-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.